A soluble tumor necrosis factor receptor mutant

Details for Australian Patent Application No. 2009253623 (hide)

Owner Shanghai Fudan-Zhangjiang BioPharmaceutical Co., Ltd. Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.

Inventors Liu, Yanjun; Yang, Tong; Shen, Yijun; Wu, Jinsong; Wu, Fang

Agent Davies Collison Cave

Pub. Number AU-A-2009253623

PCT Pub. Number WO2009/143689

Priority 200810038410.X 30.05.08 CN

Filing date 12 January 2009

Wipo publication date 3 December 2009

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/143689 Priority application(s): WO2009/143689

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253630-400-kiloampere level energy-saving and exhaust-decreasing pre-baked aluminum electrolytic cell

2009253542-Blade for a rotor of a wind or water turbine